$84.95
At close: Sep 4, 5:00 PM EST
$84.97
0.020.02%
After Hours: Aug 31, 7:26 PM EST
Crinetics Pharmaceuticals Inc
CRNXNASDAQ
M&A: Crinetics Pharmaceuticals (CRNX) was acquired by Vertex Pharmaceuticals (VRTX) on Tuesday, September 1, 2026 for $10B paid in cash
Crinetics Pharmaceuticals Inc Earnings & Forecasts
Crinetics Pharmaceuticals Inc (CRNX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Crinetics Pharmaceuticals Inc Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.22 | $-1.23 | $-1.37 | $-1.26 |
| Actual | $-1.14 | $-1.23 | $-1.29 | $-1.38 |
| Surprise | +6.56% | 0.00% | +5.84% | -9.52% |
| Revenue | ||||
| Estimate | $15.0M | $8.3M | $4.6M | $1.3M |
| Actual | $25.1M | $10.3M | $6.2M | $143000 |
| Surprise | +67.9% | +23.8% | +33.1% | -89.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.15 | $-1.09 | $-0.96 | $-0.83 |
| Revenue | ||||
| Consensus | $37.4M | $72.4M | — | — |
